Advertisement

Topics

Cancer Corporate

13:28 EST 23rd January 2019 | BioPortfolio

STEMCELL Technologies Inc

STEMCELL Technologies supports life sciences research with more than 2,500 specialized reagents, tools, and services. We offer high quality cell culture media, cell separation technologies, instruments, accessory products, and educational resources that are used by scientists performing stem cell, immunology, cancer, regenerative medicine, and cellu...

Rainier Therapeutics, Inc.

Rainier Therapeutics, Inc. is a privately-held, clinical stage biotechnology company developing a targeted biologic for the potential treatment of metastatic and early stage bladder cancer, an area of high unmet need. The company’s antibody, vofatamab (B-701) is focused specifically on the fibroblast growth factor receptor 3 (FGFR3), a known driver of...

Abcam

Abcam is a producer and distributor of research-grade antibodies and associated products, headquartered in Cambridge, UK, with a US office located in Cambridge, Massachusetts and a Japan office located in Tokyo. Our vision is to build the largest online catalog of the best antibodies in the world. Find the antibodies relevant to your research: Cancer, Cardiovascular, Chromatin, Immunology, Micr...

ImmunSYS, Inc.

ImmunSYS, Inc. is a clinical stage biopharmaceutical company focused on the development of innovative cancer immunotherapy products to improve the lives of patients with late-stage metastatic prostate cancer and other adenocarcinomas. The company’s platform technology, YourVaccx™ utilizes a novel combination of the proprietary ANTIGENerator™ energ...

IFPMA

The International Federation of Pharmaceutical Manufacturers & Associations is a non-profit, non-governmental Organization (NGO) representing national industry associations and companies from both developed and developing countries. Member companies of the IFPMA are research-based pharma-ceutical, biotech and vaccine companies. In the research and development pipeline, the pharmaceutical industry ...

FotoFinder Systems

Founded in 1991 the German company is specialized in skin cancer diagnostics by means of Automated Total Body Mapping, digital dermoscopy, in hair diagnostics, psoriasis documentation and imaging in aesthetics. Subsidiaries in Italy, Spain, UK and the U.S. and a global partner network support the company’s worldwide presence. FotoFinder won the Bavari...

Ribon Therapeutics

Ribon Therapeutics is a biotechnology company developing first-in-class therapeutics targeting novel enzyme families activated under cellular stress conditions that contribute to disease. We are exploring novel areas of biology to develop effective treatments for patients with limited therapeutic options. Leveraging a chemical biology approach and our prop...

BioNTech AG

BioNTech is Europe’s largest privately-held biopharmaceutical company pioneering the development of individualized therapies for cancer and other diseases. The Company combines all building blocks for individualized immunotherapy under one roof – from diagnostics and drug development to manufacturing. Its cutting-edge technologies range from indi...

Amunix Pharmaceuticals Inc.

Amunix Pharmaceuticals, based in Mountain View, CA, is a privately held drug discovery and development company with two proprietary technologies, XTEN® and ProTIA, that enable the rapid generation of protein therapeutics that are engineered to be fit for purpose. The company’s goal is to leverage its protein engineering platform and know-how to dis...

GT Medical Technologies, Inc.

Driven to overcome the limitations of current treatments for recurrent brain tumors and raise the standard of care, a team of brain tumor specialists joined forces and formed GT Medical Technologies with a purpose to prevent disease progression and improve quality of life for patients with recurrent brain tumors. Extensive clinical expertise informed the d...

Forbius

Forbius is a clinical stage company that designs and develops biotherapeutics for the treatment of cancer and fibrotic diseases. Forbius’ medicines are designed to radically transform patients’ lives. We use our strength in biological understanding and diverse protein engineering technologies to design superior inhibitors of validated pathways. W...

Propanc Biopharma, Inc.

Propanc Biopharma, Inc. (the "Company") is a biopharmaceutical company developing new cancer treatments initially for patients suffering from pancreatic, ovarian and colorectal cancers. The Company has developed a formulation of anti-cancer compounds, which exert a number of effects designed to control or prevent tumors from recurring and spreading through...

OncoImmunity

OncoImmunity is a machine-learning company offering a proprietary technology to address the key knowledge gaps in the prediction of bone fide immunogenic neoantigens for personalized cancer immunotherapy. OncoImmunity's software facilitates effective patient selection for cancer immunotherapy, and identifies optimal neoantigen targets for truly personal...

Ayala Pharmaceuticals, Inc.

Ayala Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company dedicated to developing targeted cancer therapies for people living with genetically defined cancers. Ayala is broadly developing its product candidates, AL101 and AL102, best-in-class gamma secretase inhibitors, with clinical and nonclinical studies underway in both solid tumors (AL...

Seer, Inc.

Seer is a life sciences and health data company focused on capturing and translating molecular insights from the proteome to enable early, pre-symptomatic detection of cancer and neurological diseases, drive earlier treatment, and improve patient outcomes. Based in South San Francisco, CA, Seer’s novel Proteograph™ platform allows for the first-e...

Atlanta Gastroenterology Associates

Founded in 1976, Atlanta Gastroenterology Associates (AGA) is one of the largest gastroenterology practices in the country dedicated to the detection and treatment of digestive and liver diseases, as well as colon cancer. With offices located throughout Metro Atlanta and North Georgia – including seven pediatric offices – its board-certified phys...

California Breast Cancer Research Program

Tvardi Therapeutics Inc.

Tvardi is a privately held, clinical-stage biopharmaceutical company headquartered in Houston, Texas. The company was founded in 2017 by Drs. David Tweardy and Ron DePinho and is focused on the development of STAT3 inhibitors. STAT3 is a key signaling molecule positioned at the intersection of many signaling pathways controlling gene networks integral to t...

Checkmate Pharmaceuticals Inc.

Checkmate Pharmaceuticals is a clinical stage company that is leveraging its expertise in the field of CpG oligonucleotides to discover and develop immunotherapies designed to increase the efficacy of existing immunotherapies and to provide new treatment options for patients and their healthcare providers. Checkmate’s lead product candidate, CMP-001, ...

Black Diamond Therapeutics

Black Diamond Therapeutics is a next-wave cancer precision medicine company. Black Diamond pioneered the development of selective medicines for patients with genetically defined cancers driven by oncogenes activated by allosteric mutations. Using its MAP platform, Black Diamond is uncovering new ways to functionally assess the mutational landscape of indiv...

Central Ohio Urology Group

Central Ohio Urology Group is a leading provider of urological services with a network of more than 18 locations throughout Ohio. Headquartered just outside of Columbus in Gahanna, Ohio, COUG provides a comprehensive suite of urological services, including general urology, advanced treatment options for bladder and prostate cancer, and radiation oncology. ...

BryoLogyx

BryoLogyx is developing a new class of drugs to enhance the response rates and treatment durability of cancer immunotherapies and anti-HIV agents. The company’s initial focus is on cancer, where it capitalizing on two recent scientific advances: the discovery that a complex natural product, bryostatin, stimulates tumor antigen production to amplify the ...

Iterion Therapeutics

Iterion Therapeutics is a venture-backed, clinical stage biotechnology company developing novel targeted cancer therapeutics. The company’s lead product, Tegavivint, is a potent and selective inhibitor of the Wnt/b-catenin signaling pathway, implicated in cell proliferation, differentiation, immune evasion and stem cell renewal. Tegavivint demonstrate...

Triumvira Immunologics Inc.

Triumvira Immunologics, Inc. is an immunotherapy company co-founded in 2015 by Dr. Jonathan Bramson at McMaster University and Bloom Burton & Co., a niche life-sciences investment bank, with the vision of developing novel T cell therapies that are safer and more efficacious than current cell therapy cancer treatments, including chimeric antigen receptor (C...

CMO Consulting, Inc.

CMO Consulting is led by Edward Garmey, M.D. a former academic hematologist-oncologist at Memorial Sloan-Kettering Cancer Center with a successful industry track-record comprising over a decade of senior leadership experience including seven prior CMO roles. CMO Consulting provides its clients, ranging from blue-chip venture capital firms to start-ups and ...

Advertisement
Quick Search
Advertisement
Advertisement

 

review and buy Cancer market research data and corporate reports here